Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects
Clinical trial NCT00650221 · COMPLETED
Trial details
- NCT number
- NCT00650221
- Sponsor
- Mylan Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2003-07-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.